Most patients recovering from NCCP will develop antibodies specific to NCCV, which are effective in killing and clearing the virus. Currently, in the absence of a vaccine and specific therapeutic drugs, plasma donation is advocated for recovered patients. Plasma can be collected as long as the patient recovers and meets the criteria for discharge, but the suitability for donation is evaluated by a physician. From the perspective of testing and treatment, it is usually recommended that recovered patients participate in plasma donation after 2 weeks of nucleic acid testing for the new coronavirus to ensure that the virus is well cleared from the body. Recovered patients should not worry too much as plasma donation will not have any adverse effects on their health.